GlassScriptPhysician profile
Elliott Wityk
NPI 1568922979
$11,738.12
in general payments reported to CMS, 2019-2025
30 companies · $4,199 in 2025
The $4,199 reported for 2025 was more than what 92% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $150 · 2022: $3,972 · 2023: $1,342 · 2024: $2,075 · 2025: $4,199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,549 · Travel and Lodging: $3,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,549.47 |
| Travel and Lodging | $3,066.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,691.09 | 2022-2025 | Citrefix, Prostep Mica, Ortholoc 3di |
| Arthrex, INC. | $1,181.30 | 2025 | |
| Titan Surgical Group, LLC | $756.90 | 2024-2025 | |
| Smith+Nephew, INC. | $281.40 | 2023-2025 | Grafix Pl, Panta 2, Taylor Spatial Frame |
| Depuy Synthes Sales INC. | $261.92 | 2022-2025 | Motoband |
| Paratek Pharmaceuticals, INC. | $224.94 | 2023-2025 | Nuzyra |
| Averitas Pharma INC. | $200.40 | 2023-2025 | Qutenza |
| Bioventus LLC | $186.56 | 2022-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Bone Support INC. | $149.84 | 2020 | |
| Osteomed LLC | $140.51 | 2022 | |
| Abbvie INC. | $87.72 | 2023-2025 | Dalvance, Teflaro |
| Pylant Medical | $82.17 | 2022-2023 | |
| Acumed LLC | $60.81 | 2024-2025 | Acumed, Acumed |
| Amgen INC. | $58.56 | 2024 | Krystexxa |
| Integra Lifesciences Corporation | $46.32 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $36.19 | 2023 | Krystexxa |
| Innovation Technologies INC | $34.71 | 2023 | Irrisept |
| Medshape, INC. | $27.84 | 2023 | |
| Ani Pharmaceuticals, INC. | $25.63 | 2023 | Purified Cortrophin Gel |
| Medtronic, INC. | $22.35 | 2024 | Intellis Adaptivestim |
| Mimedx Group, INC. | $21.83 | 2024 | |
| Acera Surgical, INC. | $21.75 | 2025 | Restrata Wound Matrix |
| Surgenex LLC | $21.07 | 2025 | Surgraft, Ardeograft, Renograft |
| Globus Medical, INC. | $19.76 | 2025 | Actify 3d, Anthem |
| Molnlycke Health Care US, LLC | $19.70 | 2023 | Exufiber Ag+, Mextra Superabsorbant, Mepilex Border Post-Op Ag |
| Abbott Laboratories | $17.47 | 2024 | Proclaim |
| Organogenesis INC. | $17.28 | 2023 | Puraply |
| Convatec INC. | $15.56 | 2024 | |
| Nuo Therapeutics | $13.40 | 2023 | |
| Nevro Corp. | $13.14 | 2024 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elliott Wityk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.